ObamaCare’s new preventive services guidelines creates huge incentives for medical lobbyists to get their prefered treatments designated as preventive care. “When government agencies are making non-scientific value judgments–e.g., are these studies reliable enough to merit an A or B recommendation? what should be the thresholds for an A or B recommendation? will the benefits of mandating this coverage outweigh the costs?–politics does even better. Witness Sen. Barbara Mikulski (D-Md) overruling a USPSTF recommendation when she ‘inserted an amendment in the [new] health-care law to explicitly cover regular mammograms for women between 40 and 50.'”